These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 3589152

  • 1. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M, Wu WH, Look ZM, Silber BM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [Abstract] [Full Text] [Related]

  • 2. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE, Hajdú P, Malerczyk V, de Looze S, Seeger K, Grötsch H.
    Clin Ther; 1987 Apr; 10(1):18-31. PubMed ID: 3450392
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA, Cooper J, Gauze JJ, Greco DS, Weise DW, Buck JM.
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S, Catz P, Creek MR, Wu B, Thomas D, Krogstad DJ, De D, Mirsalis JC, Green CE.
    Int J Toxicol; 2004 Jul; 23(3):179-89. PubMed ID: 15204721
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W, Barth H, Becker R, Frankus E, Schmidt-Böthelt E.
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [Abstract] [Full Text] [Related]

  • 7. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR.
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 13. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR.
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
    Kim YH, Yoo SD, Kim YS, Lee KH, Lee HS.
    Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
    [Abstract] [Full Text] [Related]

  • 15. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat.
    Zhang Y, Akao T, Nakamura N, Duan CL, Hattori M, Yang XW, Liu JX.
    Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191
    [Abstract] [Full Text] [Related]

  • 16. The absolute oral bioavailability of dapsone in dogs and humans.
    Pieters FA, Zuidema J.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
    Shukla UA, Marathe PH, Pittman KA, Barbhaiya RH.
    Drug Metab Dispos; 1993 Jul; 21(3):502-7. PubMed ID: 8100508
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.
    Benincosa LJ, Audet PR, Lundberg D, Zariffa N, Jorkasky DK.
    Biopharm Drug Dispos; 1996 Apr; 17(3):249-58. PubMed ID: 8983399
    [Abstract] [Full Text] [Related]

  • 19. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
    Benchaoui HA, Cox SR, Schneider RP, Boucher JF, Clemence RG.
    J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
    [Abstract] [Full Text] [Related]

  • 20. Absolute bioavailability of cefixime in man.
    Faulkner RD, Fernandez P, Lawrence G, Sia LL, Falkowski AJ, Weiss AI, Yacobi A, Silber BM.
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.